|
ZNF587 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.009600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.159600E-02 |
| Normal-vs-Stage2 |
8.173000E-01 |
| Normal-vs-Stage3 |
1.986190E-02 |
| Normal-vs-Stage4 |
9.484000E-01 |
| Stage1-vs-Stage2 |
5.121000E-01 |
| Stage1-vs-Stage3 |
3.502800E-01 |
| Stage1-vs-Stage4 |
7.082200E-01 |
| Stage2-vs-Stage3 |
3.370200E-01 |
| Stage2-vs-Stage4 |
8.460800E-01 |
| Stage3-vs-Stage4 |
4.872800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.270400E-01 |
| Normal-vs-AfricanAmerican |
7.542600E-01 |
| Normal-vs-Asian |
1.447010E-01 |
| Caucasian-vs-AfricanAmerican |
6.822000E-01 |
| Caucasian-vs-Asian |
5.852600E-01 |
| AfricanAmerican-vs-Asian |
6.128400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.954400E-02 |
| Normal-vs-Female |
5.262600E-01 |
| Male-vs-Female |
6.150300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.724400E-01 |
| Normal-vs-Extreme_Weight |
1.123650E-02 |
| Normal-vs-Obese |
9.427000E-01 |
| Normal-vs-Extreme_Obese |
5.732000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.032800E-01 |
| Normal_Weight-vs-Obese |
5.299000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.981800E-01 |
| Extreme_Weight-vs-Obese |
6.694300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.182200E-01 |
| Obese-vs-Extreme_Obese |
1.185220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.786800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.402600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.025040E-01 |
| Normal-vs-Age(81-100Yrs) |
2.738900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.024600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.964800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.955900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.317700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.347900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.714400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.197800E-01 |
| Normal-VS-Type2 PRCC |
2.023300E-03 |
| Normal-VS-KIRP CIMP |
9.672400E-01 |
| Normal-VS-Unclassified PRCC |
7.643000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.957000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.351600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.733200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.085620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.894000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.438400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.897100E-03 |
| Normal-vs-N1 |
5.576800E-01 |
| Normal-vs-N2 |
1.774610E-01 |
| N0-vs-N1 |
4.363500E-02 |
| N0-vs-N2 |
9.743600E-01 |
| N1-vs-N2 |
3.956000E-01 |
|
|
